Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malec

Showing results (651-660 of 722) with videos related to

Pageof 73
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophiliaStacy E Croteau, Dunlei Cheng, Alice J Cohen, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 2, 2009
The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation - insights from the LIPGENE studyJadwiga Hartwich, Malgorzata Malczewska Malec, Lukasz Partyka, et al.
Journal of the National Cancer Institute|June 16, 2005
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinibDaphne A Haas-Kogan, Michael D Prados, Tarik Tihan, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Energy Logistic Regression and Survival Model: Case Study of Russian ExportsKarel Malec, Socrates Kraido Majune, Elena Kuzmenko, et al.
American Journal of Hematology|May 2, 2020
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn M Malec, Dunlei Cheng, Char M Witmer, et al.
Journal of Pain and Symptom Management|August 21, 2007
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patientsDona E C Locke, Paul A Decker, Jeff A Sloan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 28, 2026
Design and optimization of the surfactant mixture ratio for oleic acid-based ophthalmic nanoemulsions prepared by the HPH technology - feasibility study for clotrimazole as a model drugAgnieszka Gawin-Mikołajewicz, Katarzyna H Malec, Dominik M Marciniak, et al.
The Oncologist|August 23, 2021
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology PatientsNatalie Reizine, Keith Danahey, Emily Schierer, et al.
Vaccine|January 13, 2024
JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak dataJennifer B Rosen, Robert J Arciuolo, Preeti Pathela, et al.
Thrombosis Research|June 4, 2017
Feasibility of the Von Willebrand disease PREVENT trialMargaret V Ragni, Nicoletta Machin, Andra H James, et al.
Pageof 73

Showing results (651-660 of 722) with videos related to

Sort By:
Pageof 73
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophiliaStacy E Croteau, Dunlei Cheng, Alice J Cohen, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 2, 2009
The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation - insights from the LIPGENE studyJadwiga Hartwich, Malgorzata Malczewska Malec, Lukasz Partyka, et al.
Journal of the National Cancer Institute|June 16, 2005
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinibDaphne A Haas-Kogan, Michael D Prados, Tarik Tihan, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Energy Logistic Regression and Survival Model: Case Study of Russian ExportsKarel Malec, Socrates Kraido Majune, Elena Kuzmenko, et al.
American Journal of Hematology|May 2, 2020
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn M Malec, Dunlei Cheng, Char M Witmer, et al.
Journal of Pain and Symptom Management|August 21, 2007
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patientsDona E C Locke, Paul A Decker, Jeff A Sloan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 28, 2026
Design and optimization of the surfactant mixture ratio for oleic acid-based ophthalmic nanoemulsions prepared by the HPH technology - feasibility study for clotrimazole as a model drugAgnieszka Gawin-Mikołajewicz, Katarzyna H Malec, Dominik M Marciniak, et al.
The Oncologist|August 23, 2021
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology PatientsNatalie Reizine, Keith Danahey, Emily Schierer, et al.
Vaccine|January 13, 2024
JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak dataJennifer B Rosen, Robert J Arciuolo, Preeti Pathela, et al.
Thrombosis Research|June 4, 2017
Feasibility of the Von Willebrand disease PREVENT trialMargaret V Ragni, Nicoletta Machin, Andra H James, et al.
Pageof 73